The Decline in FDA Enforcement Activity
Congressman Waxman’s United States House of Representatives Committee on Government Reform issued a report entitled “Prescription for Harm/The Decline in FDA Enforcement Activity” in June…
Read More »Congressman Waxman’s United States House of Representatives Committee on Government Reform issued a report entitled “Prescription for Harm/The Decline in FDA Enforcement Activity” in June…
Read More »The owner of three Miami, Florida medical equipment companies was convicted by a jury of Medicare fraud with sentencing scheduled for June 12th. This prosecution…
Read More »Answer: Monitoring postmarketing study commitments. The FDA lacks an effective system for monitoring postmarketing study commitments. See the latest OIG Report, dated June 2006.
Read More »A pharmaceutical company can violate the false claims act by submitting false statements in connection with drug applications and other records to the United States…
Read More »